Announcements

30 April 2025
Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award


We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

2024 Tu Youyou Award Laureates

Richard DiMarchi
Indiana University, USA
Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed.
Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee
   

Rolf Müller
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany;
Helmholtz Centre for Infections Research (HZI), Germany;
Saarland University, Germany
Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature.
The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee

The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.

2024 Award Committee
Committee Chair:

Committee Members (listed in alphabetical order):

  • Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
  • Prof. Binghe Wang, Georgia State University, USA;
  • Dr. Diana Pinto, University of Aveiro, Portugal;
  • Prof. Hideaki Kakeya, Kyoto University, Japan;
  • Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
  • Prof. Thomas Prisinzano, University of Kentucky, USA
  • Prof. Wei Li, University of Tennessee Health Science Center, USA.

About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

17 June 2025
Meet Us at the 29th Annual Meeting of the Japanese Society of Travel and Health, 19–20 July 2025, Nara, Japan


Conference:
The 29th Annual Meeting of the Japanese Society of Travel and Health
Organization: Japanese Society of Travel and Health
Date: 19–20 July 2025
Place: Nara, Japan

Representatives from a number of MDPI journals will be attending the 29th Annual Meeting of the Japanese Society of Travel and Health as exhibitors. The meeting will be held in Nara, Japan, from 19 to 20 July 2025.

The Japanese Society of Travel and Health (JSTH), established in 1997, has been dedicated to advancing the field of travel medicine. The 29th Annual Conference, themed “Let's learn together and create together: a new era of Travel and Health that illuminates future travel”, will focus on the following key topics:

  • Infectious disease treatment, infection control, and vaccines;
  • Mental health, chronic disease management, and medical insurance;
  • Establishment and operations of travel clinics;
  • Latest trends, including digital transformation and AI.

As an interdisciplinary platform, this conference will bring physicians, nurses, pharmacists, and travel industry experts together to discuss the most pressing global health challenges.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference above, please feel free to visit our booth. Our delegates look forward to meeting you in person and to answering any questions you may have. For more information about the conference, please visit the following website: https://www.c-linkage.co.jp/jsth29/.

13 June 2025
Empowering Academic Growth with MDPI Scientific Publishing Workshop with the Medical University of Silesia, Poland, 16 June 2025

MDPI is excited to host a scientific publishing workshop in partnership with the Medical University of Silesia, Poland. This collaboration reflects MDPI’s and the Medical University of Silesia’s shared commitment to academic research and scholarly publishing. The session will provide valuable guidance to students on how to structure and write academic articles, offering essential tools and knowledge to support their publishing journeys. The session will cover topics such as “How to Structure an Article” and “How to Write Academic Articles in English”.

Project Name Empowering Academic Growth with MDPI—Scientific Publishing Workshop with the Medical University of Silesia
Date and Time (local Time) 16 June 2025; 10:00 a.m.–1:00 p.m. (CEST)
Online /Offline Online
Venue Microsoft Teams
Institution Medical University of Silesia
Institution Banner
Schedule:
Speakers Program and Content Time
  Opening Speech 10:00–10:05 (CEST)
Mr. Marcin Biedroń How to Write Academic Articles in English? 10:05–10:25 (CEST)
  Q&A Session 10:25–10:35 (CEST)
Mr. Marcin Biedroń How to Structure an Article? 10:35–10:55 (CEST)
  Q&A Session 10:55–11:00 (CEST)
Mr. Marcin Biedroń Submissions to SCIE Journals. 11:00–11:05 (CEST)
nbsp; Q&A Session 11:05–11:10 (CEST)
Ms. Monika Mazurek Why Are Articles Rejected in Peer-Review? The Most Common Reasons and How to Avoid Them. 11:10–11:40 (CEST)
  Q&A Session 11:40–11:45 (CEST)
Ms. Monika Mazurek How to Respond to Reviewers? 11:45–12:15 (CEST)
  Q&A Session 12:15–12:20 (CEST)
Ms. Monika Mazurek Introduction to MDPI 12:20–12:30 (CEST)
  Q&A Session 12:30–12:35 (CEST)
  Event Wrap-Up 12:35–13:00 (CEST)
 

MDPI Speakers:

Mr. Marcin Biedroń

Mr. Marcin Biedroń holds an M.Sc. Eng. degree in dietetics from the Faculty of Food Technology and Human Nutrition at the University of Agriculture in Krakow, Poland. He joined MDPI in October 2021 as an Assistant Editor for the Diagnostics journal. Since then, he has progressed through several roles including Section Managing Editor and was appointed Journal Relationship Specialist in 2024. Over the past year, he has contributed to four medical journals, collaborating closely with editors, authors, and reviewers throughout the publication process. He is currently focused on enhancing the journals’ social media presence, coordinating meetings with researchers and editorial boards and representing the publishing house at international conferences across Europe.

Ms. Monika Mazurek

Ms. Monika Mazurek holds a master's degree in psychology (clinical psychology and neuroscience) from SWPS University in Warsaw. After starting her Ph.D. at Jagiellonian University, she is pursuing her clinical degree in Psychotherapy at the Faculty of Medicine, Jagiellonian University Medical College. She joined MDPI in March 2021 as an Assistant Editor for the journal Brain Sciences and became Section Managing Editor the next year. Since 2022, she has been working as a Journal Relations Specialist for several journals, including Allergies, Endocrines, Advances in Respiratory Medicine and Brain Sciences. She participated in many international congresses dedicated to medical and health sciences.

12 June 2025
Tropical Medicine and Infectious Disease Receives an Increased CiteScore of 4.7


We are pleased to share that Tropical Medicine and Infectious Disease (TropicalMed, ISSN: 2414-6366) has received an increased CiteScore of 4.7 in June 2025. The CiteScore ranks the journal 212 out of 687 titles (Q2) in the “Public Health, Environmental and Occupational Health” category and 22 out of 63 titles (Q2) in the “General Immunology and Microbiology” category, an impressive achievement for a journal running in Volume 10.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Tropical Medicine and Infectious Disease and its growing impact in tropical medicine and infectious disease.

11 June 2025
Meet Us at the 2nd Southeast Asia Ticks and Tick-Borne Diseases Symposium, 28–29 August 2025, Singapore


Conference: 2nd Southeast Asia Ticks and Tick-borne Diseases Symposium

Date: 28–29 August 2025

Location: National University of Singapore, Singapore

Join us in Singapore for the 2nd Southeast Asia Ticks and Tick-borne Diseases Symposium from 28 to 29 August 2025! This symposium aims to connect leading experts, researchers, and professionals while encouraging collaboration and knowledge exchange on ticks and tick-borne diseases (TBDs) in Southeast Asia. By featuring novel insights into tick research, TBDs in Southeast Asia, and other related concepts, this event will provide a unique platform for networking and scientific exchange, fostering a sustainable research community across ASEAN countries. It will also offer young and/or emerging scientists the chance to engage with global experts in the field.

Seize this opportunity to connect, learn, and contribute to the future of tick and TBD research in Southeast Asia. Register now and be part of this growing regional initiative!

The following journals will represent MDPI at the conference:

If you are planning to attend, feel free to reach out and start a conversation with us at our booth. Our team looks forward to meeting you in person and answering any questions you may have. For more details about the symposium, please visit the following website: https://www.gevme.com/2nd-southeast-asia-ticks-and-tick-borne-diseases-symposium.

5 June 2025
Meet Us at the 2025 International Symposium for One Health Research and Practice: From Vision to Collaboration and Action, 27–30 June 2025, Shenzhen, China


Hosts:
China One Health Network, Southern University of Science and Technology, Shenzhen Third People’s Hospital (The Second Affiliated Hospital of Southern University of Science and Technology), and The Centre for Environment & Population Health, Griffith University
Time: 27–30 June 2025
Venue: Shenzhen Third People’s Hospital, China
Conference Website: http://www.onehealth-network.com/index.php

Aim of the Symposium
The One Health Symposium series has played a pivotal role in shaping the global One Health movement. The inaugural event in 2014 established a global network of One Health researchers. The second symposium, in 2019, further strengthened this collaboration, culminating in the Pearl River Declaration. The Declaration called for enhanced regional cooperation to address emerging health threats across the Asia–Pacific. These milestones continue to shape the One Health agenda and global health security strategies.

Featuring distinguished One Health researchers and practitioners from around the world, the 3rd International Symposium for One Health Research and Practice aims to provide a platform for participants to both discuss the concepts and implementation challenges of One Health and to share successful projects and strategies from around the world to enable and facilitate more effective collaboration and action. The symposium will culminate in the creation of the Shenzhen Declaration. The Declaration calls for the strengthening of cross-regional collaboration and commitments and provides concrete steps and actionable solutions to more effectively tackle current and future global health security challenges from emerging infectious diseases.

The Importance of this Symposium
Humanity faces increasing global health challenges, both in terms of scale and complexity. As demonstrated by the One Health approach, growing health security threats from emerging and re-emerging infectious diseases need to be addressed through inter-sectoral collaboration between a diverse range of professionals with complementary skill sets, knowledge, resources, experience, and networks.

The 3rd International Symposium for One Health Research and Practice addresses this urgent need by bringing together specialists from diverse sectors, such as public health, animal health, agriculture, food safety, and environmental science. These include One Health leaders, scholars, and policymakers, in addition to new partners from AI, health economics, funding bodies, and community of practice networks. Through timely discussions and the development of practical strategies, this symposium will create a dynamic platform for productive engagement, action, and cross-sectoral partnerships to drive One Health initiatives forward.

3 June 2025
MDPI INSIGHTS: The CEO's Letter #23 - MDPI Summits Spain & Italy, Ei Compendex, and Editorial Independence

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Highlights from the MDPI Spain Summit in Barcelona (21-22 May)

In May we hosted the MDPI Spain Summit in Barcelona – our second summit in the city following the inaugural one in November 2023.


Stefan Tochev (CEO, MDPI) at the MDPI Spain Summit in Barcelona, 22 May 2025.

Creating a space for exchange of views

The goal of our summits is to bring together Chief Editors of MDPI journals from across disciplines and institutions. These intimate gatherings provide a platform to present the latest developments at MDPI and to initiate open conversations about our journals, the future of open access, and the evolving landscape of scientific publishing.

Most importantly, these are opportunities for in-person connection, providing a more meaningful space for the exchange of views and for building long-term relationships.

Exploring the future of scientific publishing in Spain

The summit took place on 21–22 May and featured a mix of MDPI presentations (including two guest presentations), roundtable discussions, and Q&A sessions. On the first day, we held a focused session with our Chief Editors to gather feedback and have open discussions on their journal development, the peer-review process, and local accreditation systems.


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI, presents MDPI’s Editorial Process and Peer Review Quality Metrics at the MDPI Spain Summit in Barcelona, 22 May 2025.

I had the pleasure of opening the Summit with a welcome address and an overview of MDPI’s recent milestones. The agenda then included the following sessions:

  • MDPI and Recent Developments in the Spanish Market – Dr. Marta Colomer (Public Affairs Specialist, MDPI)
  • MDPI Editorial Process and Peer Review Quality Metrics – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Open Access in Spain – Dr. Remedios Melero (Researcher, CSIC – guest speaker)
  • AI in Publishing and MDPI's Actions – Dr. Enric Sayas (Business Analyst, MDPI), Daniele Raimondi (Data Scientist, MDPI), and Dr. Alexandre López-Borrull (Researcher, Universitat Oberta de Catalunya – guest speaker)
  • Publication Ethics – Ana Stankovic (Research Integrity and Publication Ethics, MDPI)
  • Opening and Closing remarks were provided by Rocksy Zhang (Editorial Director, MDPI)

We are extremely grateful for the strong engagement shown by our Editors, who were clearly appreciative of the event and the discussions we had. They felt seen and heard, which is a vital prerequisite for building open channels of communication and cultivating productive long-term collaborations.


MDPI colleagues during MDPI Spain Summit in Barcelona (22 May 2025).

A big thank-you to the entire Barcelona team for organizing such a successful event!

Upcoming MDPI Summit events:

  • Italy Summit – Rome (26–27 May)
  • US Summit – Boston, MA (5–6 June)
  • France Summit – Paris (12–13 June)
  • US Summit – Houston, TX (26–27 June)
  • UK Summit – London (16–17 September)
  • Germany Summit – Berlin (18–19 September)
  • Romania Summit – Bucharest (23–24 October)
    ...with more in between, and more to follow.

Impactful Research

50 MDPI Journals Now Indexed in Ei Compendex

Indexing is a key indicator of a journal’s scientific impact. An indexed journal gives research greater visibility and credibility within the global academic community and is recognized for its quality and relevance. While many of our journals are included in major databases such as Web of Science and Scopus, MDPI also places strong emphasis on journal inclusion in subject-specific indexing platforms that align with each journal’s scope. This ensures that when you publish with MDPI, you publish with impact.

I’m pleased to share that as at May 2025, 51 of our journals are now indexed in Ei Compendex, a leading bibliographic database for engineering and applied sciences. This is a major milestone that reflects both the quality or our editorial processes and the relevance of the research we publish in these fields.

“When you publish with MDPI, you publish with impact”

Discoverability and reach

Inclusion in Ei Compendex means greater discoverability for our authors and broader reach of our journals in the fields of engineering and technology. It improves our ability to support global research and innovation, while building MDPI’s reputation in the applied sciences. This recognition is the result of the dedicated work of our editorial teams, reviewers, and authors, and of our overall commitment to excellence in publishing.

You can read our full announcement here.

Appreciative thanks to everyone involved in reaching this milestone.

Inside MDPI

 

One Year of MDPI’s Seoul Office

On 29 April, we marked one year since the opening of our Seoul office, MDPI’s first local hub in South Korea. South Korea is a key market for MDPI, currently ranking as our sixth-largest contributor to the company’s total publications, with over 89,000 MDPI articles authored by individuals affiliated with Korean institutions. Over the past 12 months, the Seoul team has made great strides in building our visibility, networks, and presence in the region.

A few highlights from the past year


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, is the Office Manager of the Seoul office.

In its inaugural year, the Seoul office focused primarily on marketing and promotional activities to support the MDPI brand locally. During that time, the team concentrated on scholar visits to local institutions, attending academic conferences, and hosting editorial board meetings.

The team also secured 10 Institutional Open Access Program (IOAP) renewals, signed three new IOAP agreements, and established one new Society affiliation.

The Seoul office also hosted its first library book fair and reached over 1,000 followers on its LinkedIn channel, which is an encouraging indication of local visibility and engagement.

“The Seoul team has made strides in building our visibility, networks, and presence in the region”

Growth plans

Later this year, we are working on opening a new Seoul office in a more central location, with room for our growing team. The new space will bring us closer to other publishing partners and provide easier access to and from the airport. The Seoul office will continue to expand its efforts in outreach and engagement as its builds its presence in South Korea.

Warm thanks to the entire Seoul team for their hard work and dedication, and to all MDPI colleagues who have contributed to this exciting chapter in our global journey.

Coming Together for Science

Highlights from the MDPI Italy Summit in Rome (26–27 May)

We closed the month of May by hosting the first MDPI Italy Summit in Rome. This was an important event for us, as Italy has consistently ranked among the top ten countries globally for open access publications over the past decade.

MDPI and Italy: Facts & Figures

  • With over 144,000 publications (as at 31 May 2025), Italy is MDPI’s third largest contributor after China and the USA.
  • In 2024, MDPI was the second-largest publishing house in Italy.
  • The 7,165 Editorial Board Members (EBMs) drawn from Italian institutions represent 8.9% of all MDPI academic editors.
  • Among these, 319 serve as Editors-in-Chief (EiCs) or Section Editors-in-Chief (SEiCs).
  • Eleven Italian EBMs were recognized as 2024 Clarivate Highly Cited Researchers.
  • In 2024, MDPI received 24,873 review reports and collaborated with 88,578 reviewers from Italy.
  • 23,131 Guest Editors from Italian institutions led 4,827 Special Issues across 248 MDPI journals.
  • MDPI partners with over 900 institutions globally, of which 17 are in Italy.

The MDPI Italy Summit in Rome


Dr. Prof. Giulio Cerullo, EiC of Applied Sciences, at the MDPI Italy Summit in Rome (27 May 2025).

Held on 26–27 May, the MDPI Italy Summit brought together 25 Chief Editors from across our journal portfolio, including some of our largest journals such as Applied Sciences, to discuss MDPI’s latest developments and collaborations in the Italian market, our use of data intelligence and AI to support strategic decision-making, a look into our editorial process, peer-review quality metrics, and conversations around research integrity and community engagement.

The Summit featured MDPI presentations followed by Q&A and concluded with a roundtable discussion. On the evening of the 26th, we hosted a dinner with our Editors to connect personally, learn more about their research, and hear feedback on journal operations and the broader academic landscape in Italy.


Gathering of Editors-in-Chief and MDPI staff at the MDPI Italy Summit in Rome (27 May 2025).

Event Agenda – 27 May

Moderated by Maddalena Favaretto (Conference Scientific Advisor, MDPI), the program featured:

  • MDPI Overview, Achievements, Latest News and Future Developments – Stefan Tochev (CEO, MDPI)
  • Country Report: Italy – Dr. Laura Perez Martin (Conference Assistant, MDPI)
  • AI in Publishing and MDPI’s Actions – Dr. Andrea Perlato (Head of Data Analytics, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Andrea, Giulia


Panel Discussion with Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI), Dr. Andrea Perlato (Head of Data Analytics, MDPI) during the MDPI Italy Summit in Rome (27 May 2025).

A big thank-you to our Conference team and everyone who worked behind the scenes to make these events run smoothly.

Closing Thoughts

Upholding Editorial Independence in Scholarly Publishing

A recent MDPI blog post written by Dr. Ioana Craciun (Scientific Communications Specialist, MDPI), “Editorial Independence and Publisher Support: Collaborating to Uphold Integrity,” highlights the important balance between editorial autonomy and publisher collaboration in academic publishing.

As the leading fully Open Access scholarly publisher, we are proud to champion editorial independence within our publishing process.

Drawing from the Committee on Publication Ethics (COPE) guidelines, the article emphasizes that while editors must have the freedom to make decisions based on scholarly merit, publishers play a critical role in providing the necessary infrastructure and tools to support the editorial process. This collaborative approach ensures the integrity of the peer review process, builds trust among authors and readers, and upholds the quality and relevance of published content.

MDPI highlights its commitment to this model by investing in research integrity specialists, AI tools for plagiarism detection, and administrative support, all aimed at empowering editors to make independent, informed decisions.

Stefan Tochev
Chief Executive Officer
MDPI AG

19 May 2025
Meet Us at the 43rd Annual Meeting of the European Society for Paediatric Infectious Diseases, 26–30 May 2025, Bucharest, Romania


MDPI will be attending the 43rd Annual Meeting of the European Society for Paediatric Infectious Diseases, taking place from 26 to 30 May 2025 in Bucharest, Romania.

The 43rd Annual Meeting of the European Society for Paediatric Infectious Diseases will be held in person in Bucharest and online. This premier meeting brings together leading researchers and specialists from across Europe and beyond, all committed to advancing the study, treatment, and prevention of infectious diseases in children.

The following MDPI journals will be represented at the conference:

If you plan to attend the conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have.

For more information about the conference, please visit the official website at https://espidmeeting.org/.

13 May 2025
Empowering Academic Growth with MDPI: A Scientific Publishing Exchange at Toronto Metropolitan University, 15 May 2025


MDPI is excited to collaborate with Toronto Metropolitan University to host an engaging Scientific Publishing Workshop aimed at empowering scholars with the knowledge and tools needed to succeed in academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving their scientific writing and effectively addressing reviewer comments, with guidance from an experienced professional. This session promises to equip attendees with valuable skills to elevate their publishing journey.

Workshop Highlights:

  • Learn How to Better Write and Structure a Research Article;
  • How to Choose Where to Publish Academic Work;
  • How to Respond to Reviewer Comments;
  • Reasons for Rejection During Pre-Check;
  • How to Navigate Through Ethics and AI Use.

Date: 15 May 2025
Time: 12:00–1:30 p.m.
Venue: Toronto Metropolitan University

Program:

Speakers

Program and Content

Time

Dr. Stephen Mora

Introduction to MDPI

12:00–12:05 p.m.

 

How to Write and Structure a Research Article

12:05–12:45 p.m.

 

How to Respond to Reviewer Comments

12:45–1:30 p.m.

Dr. Stephen Mora has an M.Sc. and Ph.D. in kinesiology and health science from York University, Canada. He started working at MDPI in May 2024 and is now the Managing Editor of IJOM, a newly transferred society journal published by MDPI. During his graduate studies and MDPI tenure, Stephen has gained extensive experience in attending conferences, meeting with scholars, and hosting online and in-person presentations.

12 May 2025
Interview with Dr. Exequiel O. J. Porta—Winner of the TropicalMed Young Investigator Award


Name: Dr. Exequiel O. J. Porta
Affiliation:
School of Pharmacy, University College London, London, WC1N 1AX, United Kingdom
Research interests:
parasitology; neglected tropical diseases; infectious diseases; drug discovery; medicinal chemistry; chemical biology; bioinformatics; proteomics

We are pleased to share our interview with him.

1. Can you briefly introduce yourself to our readers and tell us a little bit about your fields of interest?
My name is Exequiel Porta, and I am currently a Medical Research Council (MRC) Research Fellow at University College London (UCL), based in the School of Pharmacy, and Coordinator of the Health and Biological Sciences Area at the Network of Argentine Researchers in the UK (RCARU - RAICES). My work lies at the intersection of parasitology, infectious diseases, and neglected tropical diseases (NTDs), with a strong focus on medicinal chemistry, chemical biology, bioinformatics, and proteomics. My research is deeply committed to advancing our understanding of the molecular mechanisms driving these diseases and to identifying novel therapeutic targets and new chemical entities. Ultimately, my ambition is to develop effective treatments that can significantly improve the health and quality of life of underserved and vulnerable populations globally.

2. How did you become interested in your current research field?
From the earliest days of my undergraduate studies in biotechnology at the National University of Rosario, Argentina, I was driven by a belief that chemistry could be a catalyst for transformative change in global health. This conviction guided me into medicinal chemistry and chemical biology, where I sought to harness chemical innovation to address neglected medical challenges. During my Ph.D., awarded the “Argentine Society of Research in Organic Chemistry Prize” for the best doctoral thesis of the 2015–2016 period, I delved deep into prenylated compounds, pioneering strategies to confront neglected tropical diseases. Building on this foundation, my postdoctoral research in Argentina and subsequent fellowships in the United Kingdom at Durham University (COFUND Marie Skłodowska-Curie Actions, European Union) and UCL (MRC Research Fellow) propelled the growth of both my expertise and broader scientific vision. Today, my work remains fueled by a commitment to push the boundaries of drug discovery, leveraging the power of interdisciplinary science to combat infectious diseases and bring hope to underserved populations worldwide.

3. Which research topics do you think will be of particular interest to the research community in the coming years?
The research landscape is entering an era of unprecedented innovation. I believe transformative fields such as targeted protein degradation technologies (including PROTACs), RNA-targeted therapeutics, and next-generation chemoproteomic strategies will redefine drug discovery. Simultaneously, the convergence of genomics, proteomics, and artificial intelligence is accelerating the rise in personalized medicine, ushering in a future where therapies are precisely tailored to the molecular blueprint of each patient. Together, these advancements promise to expand the boundaries of what is possible, fundamentally reshaping how we understand and treat diseases.

4. Can you briefly describe the key to a happy scientific life?
A happy scientific life is built upon an enduring sense of wonder, a deep curiosity about the unknown, and a passion for discovery. It requires resilience to navigate challenges with perseverance and openness to learning from every experience, whether it is a success or failure. Yet, science is never a solitary endeavor—true fulfilment comes from belonging to a collaborative and supportive community, where mentorship, teamwork, and shared purpose thrive. Celebrating each step forward, however small, reinforces the joy of the journey. Above all, anchoring one's research in personal passion and a broader commitment to advancing human well-being transforms science into not merely a career but a profoundly rewarding way of life.

5. What is your opinion of the open access model of publishing?
I am a strong advocate for the open access publishing model, as it plays a crucial role in democratizing scientific knowledge, making research accessible to all, regardless of institutional affiliation or geographic location. Open access fosters greater collaboration, accelerates scientific discovery, and amplifies the visibility and impact of researchers’ work. Importantly, it empowers scientists in developing regions, who might otherwise face significant barriers to accessing essential information, to fully participate in and contribute to the global research community. By breaking down traditional barriers, open access drives a more inclusive, dynamic, and interconnected scientific ecosystem.

6. As the winner of this award, is there something you want to express or someone you wish to thank?
I am incredibly honored to receive the TropicalMed Young Investigator Award. This recognition is a testament not only to individual effort but to the unwavering support of the mentors, colleagues, and teams who have accompanied me throughout my journey. I am especially grateful to my early mentors at the National University of Rosario and Durham University, particularly Professors Guillermo Labadie and Patrick Steel, whose guidance was instrumental in shaping my scientific path. Profound gratitude also goes to my current mentors at UCL, Professors Geoffrey Wells and Frank Kozielski, for their invaluable support, encouragement, and mentorship. My sincere thanks go as well to Professors Patrick Steel and Paul Denny for nominating me for this award. I am equally indebted to my collaborators and students, whose passion and dedication continue to inspire and motivate me every day. I would also like to extend my heartfelt thanks to the Global Network for Neglected Tropical Diseases, of which I am a proud member, and with whom we were honored to receive the prestigious 2023 MRC Impact Prize for Outstanding Team Impact. Finally, my deepest appreciation goes to my family (Estella, Carlos, Elián, Hernán, Andrés, and Sofía), friends (impossible to mention them all), and my partner (Marianna), whose unwavering support has been my greatest source of strength throughout this journey.

Dr. Exequiel O. J. Porta’s reflections and future directions:
The most inspiring moments of my career have arisen through vibrant exchanges with mentors, colleagues, and students, moments that underscore the collaborative nature of science. Progress rarely occurs in isolation; it flourishes in environments where curiosity is nurtured, ideas are constructively challenged, and diverse perspectives are valued. One of our greatest challenges in combating neglected diseases is the persistent scarcity of resources and attention devoted to these conditions. Addressing these demands has renewed global commitment from research institutions, pharmaceutical industries, and public health policymakers. Looking forward, my team and I are particularly excited about harnessing emerging technologies such as PROTACs and further advancing activity-based protein profiling to explore parasite–host interactions and develop patient-centered therapies. To young researchers, my advice is to remain endlessly curious, embrace teamwork, and allow bold questions to guide your scientific journey. Ultimately, my aspiration is to contribute to a future where neglected tropical diseases no longer pose a burden, a future where scientific innovation translates into sustained, equitable improvements in global health. Finally, I am deeply grateful to TropicalMed not only for this prestigious award but also for providing a platform to share my journey, ideas, and aspirations with the broader scientific community.

Back to TopTop